Sientra Analysis

Sientra is undervalued with Real Value of 0.0 and Hype Value of 0.0. The main objective of Sientra delisted stock analysis is to determine its intrinsic value, which is an estimate of what Sientra is worth, separate from its market price. There are two main types of Sientra's stock analysis: fundamental analysis and technical analysis. Fundamental analysis focuses on the financial and economic factors that affect Sientra's performance, such as revenue growth, earnings, and financial stability. Technical analysis, on the other hand, focuses on the price and volume data of Sientra's stock to identify patterns and trends that may indicate its future price movements.
The Sientra stock is traded in the USA on NASDAQ Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Sientra is usually not traded on Thanksgiving Day, Christmas Day, New Year 's Day, Dr . Martin Luther King Jr 's Birthday, Washington 's Birthday, Good Friday, Memorial Day, Juneteenth Holiday, Independence Day, Labour Day. Sientra Stock trading window is adjusted to America/New York timezone. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and Sientra's ongoing operational relationships across important fundamental and technical indicators.
  
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in income.

Sientra Stock Analysis Notes

About 17.0% of the company shares are owned by institutional investors. The company recorded a loss per share of 5.26. Sientra had not issued any dividends in recent years. The entity had 1:10 split on the 23rd of January 2023. Sientra, Inc., a medical aesthetics company, develops and sells medical aesthetics products in the United States and internationally. Sientra, Inc. was incorporated in 2003 and is headquartered in Santa Barbara, California. Sientra operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange. It employs 319 people. To find out more about Sientra contact Ronald Menezes at 805 562 3500 or learn more at https://sientra.com.

Sientra Investment Alerts

Many investors view ongoing market volatility as an opportunity to purchase more delisted stocks at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. Sientra's investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding Sientra or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
Sientra is not yet fully synchronised with the market data
Sientra generated a negative expected return over the last 90 days
Sientra has high historical volatility and very poor performance
Sientra has some characteristics of a very speculative penny stock
Sientra has a very high chance of going through financial distress in the upcoming years
The company reported the previous year's revenue of 90.3 M. Net Loss for the year was (59.12 M) with profit before overhead, payroll, taxes, and interest of 41.59 M.
Sientra currently holds about 24.99 M in cash with (11.38 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.4.

Sientra Upcoming and Recent Events

Earnings reports are used by Sientra to provide an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Every quarterly earnings report provides investors with three things: an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Sientra previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
4th of April 2024
Upcoming Quarterly Report
View
9th of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
4th of April 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

Sientra Market Capitalization

The company currently falls under 'Nano-Cap' category with a current market capitalization of 2.08 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Sientra's market, we take the total number of its shares issued and multiply it by Sientra's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.

Sientra Profitablity

Sientra's profitability indicators refer to fundamental financial ratios that showcase Sientra's ability to generate income relative to its revenue or operating costs. If, let's say, Sientra is currently losing money, the management's focus should be on how to reverse that trend. However, when revenue exceeds expenses, Sientra's executives or investors may be in less hurry to break that information down - which is where profitability analysis comes into play. Gaining a greater understanding of Sientra's profitability requires more research than a typical breakdown of Sientra's financial statements. By doing a profitability analysis, companies can identify areas needing attention, and investors can make a profitable trade.
The company has Profit Margin (PM) of (0.65) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (0.48) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $0.48.

Sientra Insider Trading Activities

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Sientra insiders, such as employees or executives, is commonly permitted as long as it does not rely on Sientra's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Sientra insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.

Sientra Technical and Predictive Indicators

About Sientra Stock Analysis

Stock analysis is the technique used by a trader or investor to examine and evaluate how Sientra prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Sientra shares will generate the highest return on investment. We also built our delisted stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Delisted Stock such as Sientra. By using and applying Sientra Stock analysis, traders can create a robust methodology for identifying Sientra entry and exit points for their positions.
Sientra, Inc., a medical aesthetics company, develops and sells medical aesthetics products in the United States and internationally. Sientra, Inc. was incorporated in 2003 and is headquartered in Santa Barbara, California. Sientra operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange. It employs 319 people.

Be your own money manager

As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding Sientra to your portfolios without increasing risk or reducing expected return.

Did you try this?

Run Insider Screener Now

   

Insider Screener

Find insiders across different sectors to evaluate their impact on performance
All  Next Launch Module
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in income.
Note that the Sientra information on this page should be used as a complementary analysis to other Sientra's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the USA ETFs module to find actively traded Exchange Traded Funds (ETF) in USA.

Other Consideration for investing in Sientra Stock

If you are still planning to invest in Sientra check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Sientra's history and understand the potential risks before investing.
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Equity Valuation
Check real value of public entities based on technical and fundamental data
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
AI Investment Finder
Use AI to screen and filter profitable investment opportunities
Money Managers
Screen money managers from public funds and ETFs managed around the world
Commodity Directory
Find actively traded commodities issued by global exchanges